HUVEPHARMA is planning an initial public offering on Amsterdam’s Euronext exchange, the company has announced. The firm, a major global livestock animal health company, plans to raise €300m from the sale of new shares. See also: Poultry feed production dipped in 2020...
HUVEPHARMA has launched a new anticoccidial in the European market. The pharmaceutical giant said it had obtained a brand-specific approval registration to market its new product, Monimax, to poultry producers in the European Union. See also: Three ways to reduce...
